DOJ drops Medicare fraud case against Fresenius

The U.S. Department of Justice dismisses a lawsuit against Fresenius Medical Care AG, which was accused of running a scheme to overcharge Medicare for kidney dialysis services.

The U.S. Department of Justice dropped a lawsuit against Fresenius Medical [1] (NYSE:FMS [2]), which was accused of overcharging Medicare for kidney dialysis services.

The dismissal follows a federal appeals court's decision to vacate a ruling against Fresenius, which had lost a $83 million verdict in a lower court.